Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACT + CCRT vs CCRT in N2-3 NPC
NCT02512315Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2015
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
docetaxelcisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02512315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02512315.